Symptom monitoring in patients with lymphomas at early and long-term follow-up after autologous hematopoietic stem cell transplantation

The article represents the results of symptom monitoring in patients with malignant lymphomas at early and long-term follow-up after autologous hematopoietic stem cell transplantation (HSCT). Symptom assessment was performed using standardized symptom assessment questionnaire MDASI. The data obtained within the study provide information about the trajectory of changes of symptom profile and symptom severity at early and longterm posttransplant period. The results demonstrate the usefulness of symptom assessment in lymphoma patients who underwent HSCT.